Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

L. Ostrosky-Zeichner, C. Sable, J. Sobel, B. D. Alexander, G. Donowitz, V. Kan, C. A. Kauffman, Daniel H Kett, R. A. Larsen, V. Morrison, M. Nucci, P. G. Pappas, M. E. Bradley, S. Major, L. Zimmer, D. Wallace, W. E. Dismukes, J. H. Rex

Research output: Contribution to journalArticle

230 Citations (Scopus)

Abstract

The study presented here was performed in order to create a rule that identifies subjects at high risk for invasive candidiasis in the intensive care setting. Retrospective review and statistical modelling were carried out on 2,890 patients who stayed at least 4 days in nine hospitals in the USA and Brazil; the overall incidence of invasive candidiasis in this group was 3% (88 cases). The best performing rule was as follows: Any systemic antibiotic (days 1-3) OR presence of a central venous catheter (days 1-3) AND at least TWO of the following-total parenteral nutrition (days 1-3), any dialysis (days 1-3), any major surgery (days -7-0), pancreatitis (days -7-0), any use of steroids (days -7-3), or use of other immunosuppressive agents (days -7-0). The rate of invasive candidiasis among patients meeting the rule was 9.9%, capturing 34% of cases in the units, with the following performance: relative risk 4.36, sensitivity 0.34, specificity 0.90, positive predictive value 0.01, and negative predictive value 0.97. The rule may identify patients at high risk of invasive candidiasis.

Original languageEnglish
Pages (from-to)271-276
Number of pages6
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume26
Issue number4
DOIs
StatePublished - Apr 1 2007

Fingerprint

Invasive Candidiasis
Decision Support Techniques
Critical Care
Central Venous Catheters
Total Parenteral Nutrition
Immunosuppressive Agents
Ambulatory Surgical Procedures
Pancreatitis
Brazil
Dialysis
Steroids
Anti-Bacterial Agents
Sensitivity and Specificity
Incidence

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. / Ostrosky-Zeichner, L.; Sable, C.; Sobel, J.; Alexander, B. D.; Donowitz, G.; Kan, V.; Kauffman, C. A.; Kett, Daniel H; Larsen, R. A.; Morrison, V.; Nucci, M.; Pappas, P. G.; Bradley, M. E.; Major, S.; Zimmer, L.; Wallace, D.; Dismukes, W. E.; Rex, J. H.

In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, No. 4, 01.04.2007, p. 271-276.

Research output: Contribution to journalArticle

Ostrosky-Zeichner, L, Sable, C, Sobel, J, Alexander, BD, Donowitz, G, Kan, V, Kauffman, CA, Kett, DH, Larsen, RA, Morrison, V, Nucci, M, Pappas, PG, Bradley, ME, Major, S, Zimmer, L, Wallace, D, Dismukes, WE & Rex, JH 2007, 'Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting', European Journal of Clinical Microbiology and Infectious Diseases, vol. 26, no. 4, pp. 271-276. https://doi.org/10.1007/s10096-007-0270-z
Ostrosky-Zeichner, L. ; Sable, C. ; Sobel, J. ; Alexander, B. D. ; Donowitz, G. ; Kan, V. ; Kauffman, C. A. ; Kett, Daniel H ; Larsen, R. A. ; Morrison, V. ; Nucci, M. ; Pappas, P. G. ; Bradley, M. E. ; Major, S. ; Zimmer, L. ; Wallace, D. ; Dismukes, W. E. ; Rex, J. H. / Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. In: European Journal of Clinical Microbiology and Infectious Diseases. 2007 ; Vol. 26, No. 4. pp. 271-276.
@article{bb50eb86ade64bce9fab5346d690d984,
title = "Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting",
abstract = "The study presented here was performed in order to create a rule that identifies subjects at high risk for invasive candidiasis in the intensive care setting. Retrospective review and statistical modelling were carried out on 2,890 patients who stayed at least 4 days in nine hospitals in the USA and Brazil; the overall incidence of invasive candidiasis in this group was 3{\%} (88 cases). The best performing rule was as follows: Any systemic antibiotic (days 1-3) OR presence of a central venous catheter (days 1-3) AND at least TWO of the following-total parenteral nutrition (days 1-3), any dialysis (days 1-3), any major surgery (days -7-0), pancreatitis (days -7-0), any use of steroids (days -7-3), or use of other immunosuppressive agents (days -7-0). The rate of invasive candidiasis among patients meeting the rule was 9.9{\%}, capturing 34{\%} of cases in the units, with the following performance: relative risk 4.36, sensitivity 0.34, specificity 0.90, positive predictive value 0.01, and negative predictive value 0.97. The rule may identify patients at high risk of invasive candidiasis.",
author = "L. Ostrosky-Zeichner and C. Sable and J. Sobel and Alexander, {B. D.} and G. Donowitz and V. Kan and Kauffman, {C. A.} and Kett, {Daniel H} and Larsen, {R. A.} and V. Morrison and M. Nucci and Pappas, {P. G.} and Bradley, {M. E.} and S. Major and L. Zimmer and D. Wallace and Dismukes, {W. E.} and Rex, {J. H.}",
year = "2007",
month = "4",
day = "1",
doi = "10.1007/s10096-007-0270-z",
language = "English",
volume = "26",
pages = "271--276",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

AU - Ostrosky-Zeichner, L.

AU - Sable, C.

AU - Sobel, J.

AU - Alexander, B. D.

AU - Donowitz, G.

AU - Kan, V.

AU - Kauffman, C. A.

AU - Kett, Daniel H

AU - Larsen, R. A.

AU - Morrison, V.

AU - Nucci, M.

AU - Pappas, P. G.

AU - Bradley, M. E.

AU - Major, S.

AU - Zimmer, L.

AU - Wallace, D.

AU - Dismukes, W. E.

AU - Rex, J. H.

PY - 2007/4/1

Y1 - 2007/4/1

N2 - The study presented here was performed in order to create a rule that identifies subjects at high risk for invasive candidiasis in the intensive care setting. Retrospective review and statistical modelling were carried out on 2,890 patients who stayed at least 4 days in nine hospitals in the USA and Brazil; the overall incidence of invasive candidiasis in this group was 3% (88 cases). The best performing rule was as follows: Any systemic antibiotic (days 1-3) OR presence of a central venous catheter (days 1-3) AND at least TWO of the following-total parenteral nutrition (days 1-3), any dialysis (days 1-3), any major surgery (days -7-0), pancreatitis (days -7-0), any use of steroids (days -7-3), or use of other immunosuppressive agents (days -7-0). The rate of invasive candidiasis among patients meeting the rule was 9.9%, capturing 34% of cases in the units, with the following performance: relative risk 4.36, sensitivity 0.34, specificity 0.90, positive predictive value 0.01, and negative predictive value 0.97. The rule may identify patients at high risk of invasive candidiasis.

AB - The study presented here was performed in order to create a rule that identifies subjects at high risk for invasive candidiasis in the intensive care setting. Retrospective review and statistical modelling were carried out on 2,890 patients who stayed at least 4 days in nine hospitals in the USA and Brazil; the overall incidence of invasive candidiasis in this group was 3% (88 cases). The best performing rule was as follows: Any systemic antibiotic (days 1-3) OR presence of a central venous catheter (days 1-3) AND at least TWO of the following-total parenteral nutrition (days 1-3), any dialysis (days 1-3), any major surgery (days -7-0), pancreatitis (days -7-0), any use of steroids (days -7-3), or use of other immunosuppressive agents (days -7-0). The rate of invasive candidiasis among patients meeting the rule was 9.9%, capturing 34% of cases in the units, with the following performance: relative risk 4.36, sensitivity 0.34, specificity 0.90, positive predictive value 0.01, and negative predictive value 0.97. The rule may identify patients at high risk of invasive candidiasis.

UR - http://www.scopus.com/inward/record.url?scp=34147136535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147136535&partnerID=8YFLogxK

U2 - 10.1007/s10096-007-0270-z

DO - 10.1007/s10096-007-0270-z

M3 - Article

C2 - 17333081

AN - SCOPUS:34147136535

VL - 26

SP - 271

EP - 276

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

IS - 4

ER -